Novel bioresorbable scaffold system being developed for expanded indications LOS ALTOS, Calif., Feb. 14, 2024 /PRNewswire/ — Efemoral Medical, developer of advanced interventional bioresorbable therapies, today announced that the United States Food & Drug Administration (FDA) has granted…
Efemoral Medical Granted Breakthrough Device Designation
This post was originally published on this site